Abstract: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.

Abstract: .delta.-Amino-.gamma.-hydroxy-.omega.

Abstract: Compounds of formula I ##STR1## wherein R.sub.1 is a 2-R.sub.A -3-R.sub.B -phenyl radical, a 2-R.sub.A -4-R.sub.C -phenyl radical, a 2-R.sub.A -pyridin-3-yl radical, a 3-R.sub.A -pyridin-2-yl radical or a 1-R.sub.D -indol-3-yl radical, wherein one of the radicals R.sub.A and R.sub.B is an aliphatic or heterocycloaliphatic-aliphatic radical or free or aliphatically, araliphatically or heteroaraliphatically etherified hydroxy and the other is hydrogen, an aliphatic radical or free or esterified or amidated carboxy, R.sub.C is hydrogen, an aliphatic radical, free or aliphatically, araliphatically, heteroaraliphatically or heteroarylaliphatically etherified hydroxy or an unsubstituted or heteroaliphatically substituted amino group, and R.sub.D is an aliphatic, araliphatic or heteroaliphatic radical, one of the radicals X.sub.1 and X.sub.2 is carbonyl and the other is methylene, R.sub.2 is an aliphatic radical, R.sub.3 is unsubstituted or aliphatically substituted amino, R.sub.

Abstract: The device serves to adapt a printer to an autonomous facsimile transmission apparatus. It comprises line interface for transmitting and receiving data conveyed via a telephone line; a printing interface; an input interface for entering data derived from at least one external digital device; a coder/decoder connected to the line interface for respectively encoding and decoding data derived respectively from the input interface and from the line interface. Data derived from the input interface either towards the line interface is routed via the coder/encoder or towards the printing interface. Data derived from the line interface is routed towards the printing interface.

Abstract: This invention relates to compounds having the general formula: ##STR1## in which: R.sub.1 represents a hydrogen atom or a (C.sub.1-4) alkyl radical,R.sub.2 represents a hydrogen atom, a (C.sub.1-4) alkyl radical, a (C.sub.2-4) alkenyl radical, a (C.sub.1-4) alkoxy-(C.sub.1-4) alkyl radical or a tetrahydrofuryl- or tetrahydropyranyl-(C.sub.1-4) alkyl radical,R.sub.3 represents a hydrogen atom or a (C.sub.1-4) alkyl radical, andR.sub.4 represents a hydrogen atom or a (C.sub.1-4) alkyl radical, and their pharmaceutically acceptable acid addition salts.Said compounds have valuable bronchodilator properties.

Abstract: This invention relates to compounds having the formula: ##STR1## in which: Ar represents a phenyl, pyridyl, isoxazolyl, oxazolyl or pyrazolyl radical which may be mono- or poly-substituted with halogen atoms, hydroxy radicals, C.sub.1-4 alkyl radicals or C.sub.1-4 alkoxy radicals,R represents a hydrogen atom, a C.sub.1-4 alkyl radical, a C.sub.2-4 alkenyl radical, a C.sub.2-4 alkynyl radical, a hydroxy-C.sub.1-4 alkyl radical, a mono- or di-C.sub.1-4 alkyl-amino-C.sub.1-4 alkyl radical or a phenyl radical,R.sub.1 and R.sub.2, when taken separately, represent each a hydrogen atom or a C.sub.1-4 alkyl radical or, when taken together with the nitrogen atom to which they are attached, form a saturated or unsaturated 5- or 6-membered heterocyclic radical which may optionally contain, as second heteroatom, an oxygen or nitrogen atom and which may carry a C.sub.1-4 alkyl radical; and their therapeutically acceptable acid addition salts.